/r/LungCancerSupport

Year:

Only show posts with narrations

23andme lung cancer genetics study-thoughts?

5 upvotes • Alert-Clothes8797

Mark as read: Add to a list

Spatial profiling of non-small cell lung cancer provides insights into tumorigenesis and immunotherapy response

3 upvotes • WalkingHorse

Mark as read: Add to a list

From the IASLC Early Detection and Screening Committee Terminology Issues in Screening and Early Detection of Lung Cancer – IASLC Early Detection and Screening Committee Expert Group Recommendations

2 upvotes • WalkingHorse

Mark as read: Add to a list

Dr Riess on Treatment Developments in ALK+ and ROS1+ NSCLC

2 upvotes • Patchouli061017

Mark as read: Add to a list

Lung Cancer Genetics Study

2 upvotes • Patchouli061017

Mark as read: Add to a list

Should Low-Dose CT Screening Be Recommended for Those at Low Risk for Lung Cancer?

2 upvotes • WalkingHorse

Mark as read: Add to a list

Low molecular weight 35 kDa hyaluronan fragment HA35 in the treatment of bone metastasis pain: A case report

1 upvotes • WalkingHorse

Mark as read: Add to a list

Correlation between PD-L1 expression status and efficacy of immunotherapy as second-line or later-line therapy in advanced non-small cell lung cancer patients

1 upvotes • WalkingHorse

Mark as read: Add to a list

LISTEN>>> Driver mutation lung cancer - My lecture - Plenary Session Podcast

1 upvotes • WalkingHorse

Mark as read: Add to a list

Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis

1 upvotes • WalkingHorse

Mark as read: Add to a list

Title	Upvotes	Author	Mark as read	Favorited	Rating	Add to a list
23andme lung cancer genetics study-thoughts?	5	Alert-Clothes8797
Spatial profiling of non-small cell lung cancer provides insights into tumorigenesis and immunotherapy response	3	WalkingHorse
From the IASLC Early Detection and Screening Committee Terminology Issues in Screening and Early Detection of Lung Cancer – IASLC Early Detection and Screening Committee Expert Group Recommendations	2	WalkingHorse
Dr Riess on Treatment Developments in ALK+ and ROS1+ NSCLC	2	Patchouli061017
Lung Cancer Genetics Study	2	Patchouli061017
Should Low-Dose CT Screening Be Recommended for Those at Low Risk for Lung Cancer?	2	WalkingHorse
Low molecular weight 35 kDa hyaluronan fragment HA35 in the treatment of bone metastasis pain: A case report	1	WalkingHorse
Correlation between PD-L1 expression status and efficacy of immunotherapy as second-line or later-line therapy in advanced non-small cell lung cancer patients	1	WalkingHorse
LISTEN>>> Driver mutation lung cancer - My lecture - Plenary Session Podcast	1	WalkingHorse
Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis	1	WalkingHorse